ETF Trace

Fund report

UCITS · Ireland · Accumulating

XRS2

US small-cap equity stocks
Levler Russell 2000 by Xtrackers UCITS ETF
IE00BJZ2DD79 · XRSG · XRSU · XTRKF · DWS (Xtrackers)

1,961 holdings as of 2026-08-29 · top 10 = 3.2% · TER 0.30% · P/E 18.7

Add to portfolioStart with this fund, then add the others you hold.
Concentration
Well diversifiedtop 10 = 3.2%
diversifiedconcentrated
GROWTH · PRICE DEVELOPMENTrebased to 0%
Holdings
1,961
as of 2026-08-29
Top 10
3.2%
TER
0.30%
cheaper than 37% of peers
Net assets
€2.50B
reported in EUR
Largest
0.4%
P / E
18.7
covers 64% by weight
Sections
Holdings as of 2026-08-29.
01Overview
the fund's regulatory facts
Distribution
Accumulating
Fund currency
USD
Domicile
Ireland
Structure
Open-ended
First listed
2015-03-23
Volatility 1Y
18.0%
Tracked index
RUSSELL 2000 TR INDEX (USD)
How it tracks
Physical, optimised
Risk rating
5 of 7
Lends its stock
Yes
02Valuation and performance
market price return · as of 2026-09-03
1M
-1.6%
3M
+1.3%
6M
+15.2%
YTD
+19.2%
1Y
+27.3%
Trackingfund minus RUSSELL 2000 TR INDEX (USD) · annualised
1Y return gap
-0.26 pp/yr
3Y return gap
-0.11 pp/yr
5Y return gap
-0.09 pp/yr
3Y tracking error
0.07%

A positive return gap means the fund finished ahead of the index over that window. The 3Y tracking error shows how variable that monthly gap was; lower means steadier tracking. MethodologyReturn gap and tracking errorReturn gap is the fund's return minus its index over the same months, converted to a yearly rate. Tracking error is the annualised standard deviation of those monthly fund-minus-index returns. Both lines come from the manager's own chart, in the same currency and the exact index variant the fund tracks. We use month-end values so different intraday valuation times are not mistaken for tracking error.. Not investment advice.

Valuation1,743 companies covered · weighted, profitable holdings only
18.7
price / earnings
MethodologyCompany-data coverageThe rest is 34% loss-making companies, which carry no P/E by the positive-earner convention; 2% cannot be reliably linked to the financial and market data used in this analysis. We exclude uncertain matches rather than estimate them.
-0.1%
MethodologyEarnings yieldP/E is price over earnings; earnings yield is the reverse, earnings over price, and reads like a bond yield. P/E covers only the profitable holdings, since a loss-making company has no meaningful P/E. Earnings yield counts the loss-makers too, so it covers more of the fund and can fall below zero when the holdings lose money overall.
covers 97% by weight
1.94
price / book
covers 87% by weight

Computed from company filings and reported position values. MethodologyPortfolio valuationComputed by us from each company's own financial statements and the position values funds report, currency-adjusted and weighted harmonically. P/E covers profitable holdings only. Book value uses the most recent reported quarter.. Not investment advice.

03Holdings
50 largest · as of 2026-08-29
#CompanyIdentifierWeight
1JFROG LTD ILFROG
0.4
2MOOG INC. USMOG/A
0.3
3UMB Financial Corp USUMBF
0.3
4GLAUKOS CORPORATION USGKOS
0.3
5Cytokinetics Inc USCYTK
0.3
6BRINKER INTERNATIONAL, INC. USEAT
0.3
7TWIST BIOSCIENCE CORP USTWST
0.3
8BRIGHTSPRING HEALTH SERVICES, INC. USBTSG
0.3
9Krystal Biotech Inc USKRYS
0.3
10Praxis Precision Medicines Inc USPRAX US
0.3
11FIRSTCASH HOLDINGS, INC. USFCFS
0.3
12Protagonist Therapeutics Inc USPTGX
0.3
13Viasat Inc USVSAT
0.3
14OLD NATIONAL BANCORP USONB
0.3
15SM Energy Co USSM
0.3
16HUT 8 CORP. USHUT US
0.3
17Caretrust Reit Inc USCTRE
0.3
18Jackson Financial Inc USJXN
0.3
19Crinetics Pharmaceuticals Inc USCRNX
0.3
20InterDigital Inc USIDCC
0.3
21Ryman Hospitality Properties Inc USRHP
0.3
22SSR Mining Inc USSSRM
0.3
23Alkermes PLC IEALKS
0.3
24TG THERAPEUTICS, INC. USTGTX
0.3
25Vaxcyte, Inc. USPCVX US
0.3
26COMPASS, INC USCOMP US
0.3
27HEALTHEQUITY, INC. USHQY
0.2
28Fluor Corp USFLR
0.2
29Commercial Metals Co USCMC
0.2
3010X GENOMICS INC-CLASS A USTXG
0.2
31US DOLLAR USUSD
0.2
32Kymera Therapeutics Inc USKYMR US
0.2
33StoneX Group Inc USSNEX
0.2
34ESCO TECHNOLOGIES INC. USESE
0.2
35RIOT PLATFORMS, INC. USRIOT US
0.2
36Terex Corp USTEX
0.2
37FEDERAL SIGNAL CORPORATION USFSS
0.2
38ZURN ELKAY WATER SOLUTIONS CORPORATION USZWS
0.2
39SILICON LABORATORIES INC. USSLAB
0.2
40Oscar Health Inc USOSCR
0.2
41ARCOSA, INC. USACA
0.2
42EnerSys USENS
0.2
43TERRENO REALTY CORP USTRNO
0.2
44Spyre Therapeutics, Inc. USSYRE
0.2
45Zeta Global Holdings Corp USZETA
0.2
46Qualys Inc USQLYS
0.2
47PBF ENERGY INC. USPBF
0.2
48HIMS & HERS HEALTH, INC. USHIMS
0.2
49The Macerich Company USMAC
0.2
50Valley National Bancorp USVLY
0.2
Add this fund to your portfolio →
04Exposure
Equity 99.8%
By sector
Healthcare20.5%
Financial Services18.8%
Industrials14.0%
Technology13.0%
Consumer Cyclical9.1%
Energy6.4%
Real Estate5.6%
Materials4.3%
Utilities2.7%
Communication Services2.3%
Consumer Defensive1.9%
By country
USUnited States93.5%
CACanada1.4%
BMBermuda1.2%
KYCayman Islands0.7%
CHSwitzerland0.6%
IEIreland0.6%
ILIsrael0.5%
GBUnited Kingdom0.3%
CurrencyUSD 95.5% CAD 1.4% EUR 0.8% CHF 0.6% GBP 0.5%
Issuer's scenario analysisaverage return per year over 5 years
Stress
-24.6%
Unfavourable
+0.6%
Moderate
+8.2%
Favourable
+17.3%
06Where it trades
12 exchanges
ExchangeMICListed since
Börse FrankfurtFRAA2015-03-23
Börse StuttgartSTUB2015-03-23
XetraXETA2015-03-23
London Stock ExchangeXLON2015-03-27
Borsa ItalianaETFP2015-04-09
Börse DüsseldorfDUSD2015-06-15
Börse MünchenMUNB2016-03-23
Börse HamburgHAMN2016-08-01
TradegateXGAT2016-12-23
Börse HannoverHAND2024-12-09
Nasdaq StockholmXSTO2025-08-20
SIX Swiss ExchangeXSWX–

Also admitted to 44 other venues, mostly multilateral trading facilities and regional segments.

See this fund inside your whole portfolio

Paste every fund you hold and see the companies you actually own, merged across all of them, with overlap, concentration and portfolio P/E. You can also test what adding this ETF would change.

Add to portfolio →